Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.

Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.

Item
http://www.wikidata.org/entity/Q36321464
Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).The involvement of endothelial mediators in leprosy.Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.Comparative evaluation of antibody detection tests to facilitate the diagnosis of multibacillary leprosy.Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosyELISA-based assay of immunoglobulin G antibodies against mammalian cell entry 1A (Mce1A) protein: a novel diagnostic approach for leprosy.Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China
P2860

Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.

Item
http://www.wikidata.org/entity/Q36321464
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Multibacillary leprosy patient ...... y to develop type 2 reactions.
@ast
Multibacillary leprosy patient ...... y to develop type 2 reactions.
@en
type
label
Multibacillary leprosy patient ...... y to develop type 2 reactions.
@ast
Multibacillary leprosy patient ...... y to develop type 2 reactions.
@en
prefLabel
Multibacillary leprosy patient ...... y to develop type 2 reactions.
@ast
Multibacillary leprosy patient ...... y to develop type 2 reactions.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Multibacillary leprosy patient ...... ty to develop type 2 reactions
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932